Literature DB >> 8553354

A screening system for antiviral compounds against herpes simplex virus type 1 using the MTT method with L929 cells.

K Sudo1, K Konno, T Yokota, S Shigeta.   

Abstract

We developed the improved MTT assay system for in vitro evaluation of anti-HSV-1 agents using L929 cells derived from mouse connective tissue. This assay system provides results in 4 days using a 96-well microplate. The EC50 values of several anti-HSV agents (ACV, BVaraU, and others) were found to be similar to those obtained by the plaque reduction method using MRC-5 cells. The present MTT assay is rapid, accurate, and may be useful as an automatic screening system for evaluation of anti-HSV-1 compounds.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8553354     DOI: 10.1620/tjem.176.163

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

1.  Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.

Authors:  Bushra Yasin; Wei Wang; Mabel Pang; Natalia Cheshenko; Teresa Hong; Alan J Waring; Betsy C Herold; Elizabeth A Wagar; Robert I Lehrer
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  Frog skin cultures secrete anti-yellow fever compounds.

Authors:  Carolina Muñoz-Camargo; Margarita Correa Méndez; Vivian Salazar; Johanna Moscoso; Diana Narváez; Maria Mercedes Torres; Franz Kaston Florez; Helena Groot; Eduardo Mitrani
Journal:  J Antibiot (Tokyo)       Date:  2016-04-06       Impact factor: 2.649

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.